News | November 19, 2013

Age Affects Short-Term Quality of Life After Breast Biopsy

clinical trial study breast biopsy system women's health mammography systems
November 19, 2013 — Breast biopsies can adversely affect short-term quality of life, and the effects are more pronounced in younger patients, according to a new study published online in the journal Radiology.
 
More than 500,000 women in the United States have a breast biopsy each year. In the percutaneous method, a physician uses a needle to remove several small samples from the area of interest for pathological analysis. Percutaneous biopsies are associated with fewer complications than the surgical approach, but there are still significant short-term side effects, including pain and emotional distress.
 
“Short-term experiences can have a long-term impact,” said Janie Lee, M.D., M.Sc., associate professor of radiology, University of Washington School of Medicine and director, Seattle Cancer Care Alliance (SCCA). “If people have a less-than-positive experience during biopsy, then they might be less likely to come back for screening the next time they are due.”
 
To learn more about the impact of percutaneous biopsy, researchers at Massachusetts General Hospital (MGH) surveyed women two to four days after the procedure. They used a tool called the Testing Morbidities Index (TMI), a survey that assesses short-term quality of life based on seven attributes, including pain/discomfort and fear/anxiety before and during the procedure and physical and mental function afterwards.
 
The patients rated each characteristic on a scale of one to five, and the final score was adjusted to a scale ranging from 0 for the worst possible experience to 100 for no adverse quality of life effects.
 
The 188 women, ranging in age from 22 to 80 years, had a mean TMI score of 82 out of 100. Patient age was the only significant independent predictor of the TMI score, which decreased by approximately three points for every decade decrease in age. The mean TMI score for women less than 40 years old was 76.4.
 
“The most important result from this study is that women have short-term decreases in quality of life related to breast biopsy,” said Lee. “When we looked at the predictors of quality of life score, we found that the strongest predictor is younger age.”
 
Lee noted that the results are surprising at first glance, considering that younger women as a group generally are healthier than their older counterparts. She pointed to the significant role of anxiety as a major factor in explaining the differences.
 
“The prospect of life-threatening disease can produce a lot of anxiety in anyone,” Lee said. “Younger women typically have less experience with the health care system in general, and it may be their first time going through a diagnostic testing experience.”
 
The study findings suggest that tailored pre-biopsy counseling may better prepare women for percutaneous biopsy procedures.
 
“By better explaining what patients can expect during the biopsy experience, we can minimize anxiety before and after the procedure,” Lee said.
 
Researchers at MGH, led by Shannon Swan, M.D., are using the TMI tool to study other screening experiences like colonoscopy to learn ways to improve the diagnostic testing process for patients. 
 
For more information: radiology.rsna.org, www.rsna.org

Related Content

Breast Density Advocate Nancy M. Cappello Passes Away

Nancy Cappello. Image courtesy of AreYouDense.org.

News | Breast Density | November 15, 2018 | Jeff Zagoudis, Associate Editor
Imaging Technology News extends its condolences to the family, friends and colleagues of Nancy M. Cappello, Ph.D., who...
Life Image and Mendel.ai Bringing Artificial Intelligence to Clinical Trial Development
News | Artificial Intelligence | November 15, 2018
Life Image and Mendel.ai announced a new strategic partnership that will facilitate the adoption and enhancement of...
Artificial Intelligence Predicts Alzheimer's Years Before Diagnosis
News | Neuro Imaging | November 14, 2018
Artificial intelligence (AI) technology improves the ability of brain imaging to predict Alzheimer’s disease, according...
Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
The MOZART Supra Specimen Tomosynthesis System is the latest generation of 3-D imaging for breast cancer surgery.
News | Breast Imaging | November 08, 2018
KUBTEC announced the launch of a new innovation in the treatment of breast cancer. The Mozart Supra Specimen...
Feature | Breast Imaging | November 07, 2018 | By Jeff Zagoudis
Breast imaging technology has experienced major growth over the last decade or so, and a new report suggests the mark
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...